CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Units | −5,093 | 10,186 | ||
| 2024-02-16 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Units | −5,329 | 15,987 | ||
| 2024-02-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +21,009 | 680,231 | ||
| 2024-02-16 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −11,292 | $36.10 | $408K | 668,939 |
| 2024-02-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +16,875 | 685,814 | ||
| 2024-02-16 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −9,070 | $36.10 | $327K | 676,744 |
| 2024-02-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Restricted Stock Units | −21,009 | 42,018 | ||
| 2024-02-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Restricted Stock Units | −16,875 | 50,624 | ||
| 2024-02-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion | +3,386 | 160,529 | ||
| 2024-02-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Shares withheld for taxes | −1,208 | $35.91 | $43K | 159,321 |
| 2024-02-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Grant or award | +8,479 | 167,800 | ||
| 2024-02-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Shares withheld for taxes | −3,832 | $35.91 | $138K | 163,968 |
| 2024-02-15 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Restricted Stock Units | −3,386 | 3,386 | ||
| 2024-02-15 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion | +1,254 | 11,345 | ||
| 2024-02-15 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −686 | $35.91 | $25K | 10,659 |
| 2024-02-15 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Units | −1,254 | 1,254 | ||
| 2024-02-15 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +13,092 | 651,096 | ||
| 2024-02-15 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −7,036 | $35.91 | $253K | 644,060 |
| 2024-02-15 | Torley Helen PRESIDENT AND CEO | Grant or award | +32,781 | 676,841 | ||
| 2024-02-15 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −17,619 | $35.91 | $633K | 659,222 |
Page 33 of 48 · 944 trades